Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 13Squamous Cell Carcinoma of Head and Neck 11Esophageal Neoplasms 11Uterine Cervical Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Head and Neck Neoplasms 7Pancreatic Neoplasms 6Oropharyngeal Neoplasms 6Nasopharyngeal Carcinoma 6Carcinoma, Squamous Cell 5Esophageal Squamous Cell Carcinoma 3Carcinoma 3Thymoma 2Stomach Neoplasms 2Neoplasms by Site 2Neoplasms 2NSCLC 2Lymphoma 2Hypopharyngeal Neoplasms 2Glioblastoma 2Colorectal Neoplasms 2Adenocarcinoma Of Esophagus 2Urinary Bladder Neoplasms 1Thrombocytopenia 1Small Cell Lung Carcinoma 1Sinonasal undifferentiated carcinoma 1Sinonasal Squamous Cell Carcinoma 1SCLC, Extensive Stage 1Resectable Esophageal Cancer 1Rectal Malignant Neoplasms 1

Interventions

Gemcitabine 53Bevacizumab 52Cyclophosphamide 49Docetaxel 42Carboplatin 40pembrolizumab 37Paclitaxel 36Fluorouracil 36Cisplatin 35Radiotherapy 31Oxaliplatin 31Capecitabine 29Irinotecan 28Dexamethasone 27Leucovorin 25Cetuximab 25Nivolumab 24Doxorubicin 22Drug Therapy 21Erlotinib Hydrochloride 20Pemetrexed 19durvalumab 18trametinib 17fludarabine 16atezolizumab 16Trastuzumab 16Sunitinib 16Rituximab 16Prednisone 16Sorafenib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Neoplasms × Chemoradiotherapy × Clear all
NCT01037049 2018-09-17

Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks

Royal Marsden NHS Foundation Trust

Phase 2 Unknown
237 enrolled
Gastrointestinal

Adenocarcinoma, Carcinoma, Adenocarcinoma, Mucinous, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms, Neoplasms, Cystic, Mucinous, and Serous

NCT01507103 2017-01-13

SPRINT

Merck KGaA, Darmstadt, Germany

Phase 2 Completed
124 enrolled 9 charts
Gastrointestinal

Carcinoma, Neoplasms, Neoplasms by Site, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡